Clinical features and personality traits associated with psychological distress in systemic sclerosis patients

Journal of Psychosomatic Research

Volumn 62, Issue 1, 2007, Pages 47-56

  Hyphantis, Thomas N ^a   Tsifetaki, Niki ^a   Pappa, Christina ^a   Voulgari, Paraskevi V ^a   Siafaka, Vasiliki ^a   Bai, Marina ^a   Alamanos, Yannis ^a   Drosos, Alexandros A ^a   Mavreas, Venetsanos ^a  

^a UNIVERSITY OF IOANNINA   (Greece)

Author keywords

Depression; Ego mechanisms of defense; Personality; Psychological distress; Sense of coherence; Systemic sclerosis

Indexed keywords

ADULT; AGED; ANXIETY; ARTHRITIS; ARTICLE; CLINICAL FEATURE; CONTROLLED STUDY; DEPRESSION; DISEASE ASSOCIATION; DISEASE DURATION; DISTRESS SYNDROME; FEMALE; GENERAL HEALTH QUESTIONNAIRE; HUMAN; MAJOR CLINICAL STUDY; MALE; MEDICAL INFORMATION SYSTEM; MENTAL DISEASE; PERSONALITY; PSYCHIATRIC DIAGNOSIS; PSYCHOSIS; SELF REPORT; SYSTEMIC SCLEROSIS;

ADAPTATION, PSYCHOLOGICAL; ADULT; AGE FACTORS; AGED; ANXIETY DISORDERS; ARTHRALGIA; CHARACTER; DEFENSE MECHANISMS; DEPRESSIVE DISORDER; ESOPHAGEAL DISEASES; FEMALE; HUMANS; INTERVIEW, PSYCHOLOGICAL; MALE; MIDDLE AGED; PERSONALITY INVENTORY; PSYCHOTIC DISORDERS; SCLERODERMA, SYSTEMIC; SICK ROLE; SICKNESS IMPACT PROFILE; STATISTICS;

EID: 33845577452     PISSN: 00223999     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jpsychores.2006.07.028     Document Type: Article

References (48)

1. Medsger T. Systemic sclerosis (scleroderma), clinical aspects. In: Koopman W. (Ed). Arthritis and allied conditions. 13th ed. (1996), Williams and Wilkins, Baltimore 1433-1464
2. Legerton C., Smith E., and Silver R. Systemic sclerosis (scleroderma). Clinical management of its major complications. Rheum Dis Clin North Am 21 (1995) 203-216
3. Haythornthwaite J., Heinberg L., and McGuire L. Psychologic factors in scleroderma. Rheum Dis Clin North Am 29 (2003) 427-439
4. Danieli E., Airo P., Bettoni L., Cinquini M., Antonioli C., Cavazzana I., Franceschini F., and Cattaneo R. Health-related quality of life measured by the Short Form 36 (SF-36) in systemic sclerosis: correlations with indexes of disease activity and severity, disability, and depressive symptoms. Clin Rheumatol 24 (2005) 48-54
5. Stewart A., Greenfield S., Hays R., Wells K., Rogers W., Berry S., McGlynn E., and Ware Jr. J. Functional status and well-being of patients with chronic conditions. Results from the Medical Outcomes Study. JAMA 18 262 (1989) 907-913
6. Buchi S., Sensky T., Allard S., Stoll T., Schnyder U., Klaghofer R., and Buddeberg C. Sense of coherence-a protective factor for depression in rheumatoid arthritis. J Rheumatol 25 (1998) 869-875
7. Roca R., Wigley F., and White B. Depressive symptoms associated with scleroderma. Arthritis Rheum 39 (1996) 1035-1040
8. Matsuura E., Ohta A., Kanegae F., Haruda Y., Ushiyama O., Koarada S., Togashi R., Tada Y., Suzuki N., and Nagasawa K. Frequency and analysis of factors closely associated with the development of depressive symptoms in patients with scleroderma. J Rheumatol 30 (2003) 1782-1787
9. Angelopoulos N., Drosos A., and Moutsopoulos H. Psychiatric symptoms associated with scleroderma. Psychother Psychosom 70 (2001) 145-150
10. Bradley L., and Alberts K. Psychological and behavioral approaches to pain management for patients with rheumatic disease. Rheum Dis Clin North Am 25 (1999) 215-232 [viii]
11. Nietert P., Mitchell H., Bolster M., Curran M., Tilley B., and Silver R. Correlates of depression, including overall and gastrointestinal functional status, among patients with systemic sclerosis. J Rheumatol 32 (2005) 51-57
12. Hyphantis T., Bai M., Siafaka V., Georgiadis A., Voulgari P., Mavreas V., and Drosos A. Psychological distress and personality traits in early rheumatoid arthritis: a preliminary survey. Rheumatol Int 26 (2006) 828-836
13. Caine T., Foulds G., and Hope K. Manual of hostility and direction of hostility questionnaire (1967), University of London Press, London
14. Bond M. An empirical study of defense styles: the defense style questionnaire. In: Vaillant G. (Ed). Ego mechanisms of defense: a guide for clinicians and researchers (1992), American Psychiatric Press, Washington (DC)
15. Antonovsky A. The structure and properties of the sense of coherence scale. Soc Sci Med 36 (1993) 725-733
16. American Rheumatism Association Diagnostic and Therapeutic Committee. Subcommittee for scleroderma criteria: preliminary criteria for the classification of systemic sclerosis (scleroderma). Arthritis Rheum 23 (1980) 581-590
17. LeRoy E., Fleischmajer R., Jablonska S., Krieg T., Medsger Jr. T., Rowell N., and Wollheim F. Scleroderma (systemic sclerosis): classification, subsets and pathogenesis. J Rheumatol 15 (1988) 202-205
18. Goldberg D., and Hillier V. A scaled version of the general health questionnaire. Psychol Med 9 (1979) 139-145
19. Garyfallos G., Karastergious A., Adamopoulou A., Moutzoukis C., Alagiozidou E., Mala D., and Garyfallos A. Greek version of the General Health Questionnaire: accuracy of translation and validity. Acta Psychiatr Scand 84 (1991) 371-378
20. Chandarana P., Eals M., Steingart A., Bellamy N., and Allen S. The detection of psychiatric morbidity and associated factors in patients with rheumatoid arthritis. Can J Psychiatry 32 (1987) 356-361
21. Derogatis L. SCL-90-R: administration, scoring, and procedure manual. 3rd ed (1994), National Computer Systems, Minneapolis (Minn)
22. Parker J., Buckelew S., Smarr K., Buescher K., Beck N., Frank R., Anderson S., and Walker S. Psychological screening in rheumatoid arthritis. J Rheumatol 17 (1990) 1016-1021
23. Donias S., Karastergiou A., and Manos N. Standardization of the symptom checklist-90-R rating scale in a Greek population. (in Greek with English abstract). Psychiatriki 2 (1991) 42-48
24. Hyphantis T., Kaltsouda A., Triantafillidis J., Platis O., Karadagi S., Christou K., Mantas C., Argyropoulos A., and Mavreas V. Personality correlates of adherence to type 2 diabetes regimens. Int J Psychiatry Med 35 (2005) 103-107
25. Hyphantis T., Triantafillidis J., Pappa S., Mantas C., Kaltsuoda A., Cherakakis P., Alamanos Y., Manousos O., and Mavreas V. Defense mechanisms in inflammatory bowel disease. J Gastroenterol 40 (2005) 24-30
26. Callahan L., and Pincus T. The Sense of Coherence scale in patients with rheumatoid arthritis. Arthritis Care Res 8 (1995) 28-35
27. Hawley D., Wolfe F., and Cathey M. The sense of coherence questionnaire in patients with rheumatic disorders. J Rheumatol 19 (1992) 1912-1918
28. Karalis I., Langius A., Tsirogianni M., Faresjo T., Nettelbladt P., and Lionis C. The translation-validation of the sense of coherence scale into Greek and its use in primary health care. Arch Hell Med 21 (2004) 195-203 [In Greeks with English abstract]
29. Clements P., Lachenbruch P., Siebold J., White B., Weiner S., Martin R., Weinstein A., Weisman M., Mayes M., Colloer D., et al. Inter and intraobserver variability of total skin thickness score (Modified Rodnan TSS) in systemic sclerosis. J Rheumatol 22 (1995) 1281-1285
30. Bruce B., and Fries J. The Stanford health assessment questionnaire (HAQ): a review of its history, issues, progress, and documentation. J Rheumatol 30 (2003) 167-178
31. Clements P., Becvar R., Drosos A., Ghattas L., and Gabrielli A. Assessment of gastrointestinal involvement. Clin Exp Rheumatol 21 Suppl 29 (2003) S15-S18
32. Matucci-Cericic M., D'Angelo S., Denton C., Vlachoyiannopoulos P., and Silver R. Assessment of lung involvement. Clin Exp Rheumatol 21 Suppl 29 (2003) S19-S23
33. Steen V., Mayes M., and Merkel P. Assessment of kidney involvement. Clin Exp Rheumatol 21 Suppl 29 (2003) S29-S31
34. Altman D. Practical statistics for medical research (1991), Chapman and Hall, London 285
35. Meakin C. Screening for depression in the medically ill. The future of the paper and pencil tests. Br J Psychiatry 160 (1992) 212-216
36. Benrud-Larson L., Haythornthwaite J., Boling C., Reed J., White B., and Wigley F. The impact of pain and symptoms of depression in scleroderma. Pain 95 (2002) 267-275
37. Moreno J., Fuhriman A., and Selby M. Measurement of hostility, anger, and depression in depressed and nondepressed subjects. J Pers Assess 61 (1993) 511-523
38. Malcarne V., and Greenbergs H. Psychological adjustment to systemic sclerosis. Arthritis Care Res 9 (1996) 51-59
39. Fishbain D., Cutler R., Rosomoff H., and Rosomoff R. Chronic pain-associated depression: antecedent or consequence of chronic pain? A review. Clin J Pain 13 (1997) 116-137
40. Rudy T., Kerns R., and Turk D. Chronic pain and depression: toward a cognitive-behavioral mediation model. Pain 35 (1988) 129-140
41. Wigley F. Clinical aspects of systemic and localized scleroderma. Curr Opin Rheumatol 6 (1994) 628-636
42. Laufer I., Snape W., Shiau Y.-F., Levine G., and Jiminez S. The gastrointestinal manifestations of scleroderma: pathogenesis and management. Gastroenterology 79 (1980) 155-166
43. Kennedy B., Schwab J., and Hyde J. Defense styles and personality dimensions of research subjects with anxiety and depressive disorders. Q Psychiatry 72 (2001) 251-262
44. DeFife J., and Hilsenroth M. Clinical utility of the Defensive Functioning Scale in the assessment of depression. J Nerv Ment Dis 193 (2005) 176-182
45. Lee P., Bruni J., and Sukenik S. Neurological manifestations of systemic sclerosis. J Rheumatol 11 (1984) 480-483
46. Sandell R., Blomberg J., Lazar A., Carlsson J., Broberg J., and Schubert J. Varieties of long-term outcome among patients in psychoanalysis and long-term psychotherapy. A review of findings in the Stockholm Outcome of Psychoanalysis and Psychotherapy Project (STOPP). Int J Psychoanal 8 Pt 5 (2000) 921-942
47. Szymona K. Changes of sense of coherence (SOC) after psychotherapy in neurotic patients. Psychiatr Pol 39 (2005) 659-668
48. Sack M., Kunsebeck H., and Lamprecht F. Sense of coherence and psychosomatic treatment outcome. An empirical study of salutogenesis. Psychother Psychosom Med Psychol 47 (1997) 149-155